Binocrit®
ACTIVE PRINCIPLE:
epoetin alfa
INDICATION:
Anemia secondary to oncological processes
end-stage renal failure
DATE:
28/08/2007
STATUS:
Authorized
ACTIVE PRINCIPLE:
epoetin alfa
INDICATION:
Anemia secondary to oncological processes
end-stage renal failure
DATE:
28/08/2007
STATUS:
Authorized